Assistant Professor of Ophthalmology

Vitreoretinal Surgery and Ocular Oncology Services

Medical School 

Albany Medical College

Residency

Duke Eye Center, Chief Resident

Fellowship(s)

Vitreoretinal surgery, clinical and research, Duke Eye Center

Ocular Oncology, Moorfields Eye Hospital and St. Bartholemew's Hospital, London, England

Background

Prithvi Mruthyunjaya, MD, specializes in the diagnosis and management of primary ocular cancers, including ocular surface and iris tumors, malignant uveal melanoma, and retinoblastoma. He will assist medical oncologists in the management of vision problems in patients with non-ocular cancers including screening for metastatic eye disease and cancer treatment (chemotherapy or radiotherapy)-related complications. He works closely with physicians from the Duke Comprehensive Cancer center and coordinates multi-disciplinary care.

Mruthyunjaya also specializes in the evaluation, diagnosis and surgical treatment of diseases of the retina including diabetic retinopathy, age-related macular degeneration (AMD), retinal vascular disease and complex retinal detachments. His expertise encompasses the latest advances in vitreoretinal surgical techniques including macular translocation for advanced AMD, all forms of retinal laser surgery - photodynamic therapy, laser photocoagulation, and transpupillary thermotherapy - and administering intraocular injections to treat macular degeneration and diabetes.

He continues to be actively involved in the education of medical students, residents, and fellows at the Eye Center.

Phone

919.684.8434

Fax

919.681.6474

Research Interests

Mruthyunjaya's clinical and laboratory research interests focus on collaborative research in ocular oncology to develop new vision and eye sparing treatments for ocular melanoma. He also seeks improved methods to detect intraocular tumors.

Representative Publications

1. Mruthyunjaya P, Simon JW, Pickering JD, Lininger LL. Subjective and Objective Outcomes of Strabismus Surgery in Children. Journal of Pediatric Ophthalmology and Strabismus. 1996, 33(3), 167-70.
2. Mruthyunjaya P, Meyer DR. Juvenile xanthogranuloma of the lacrimal sac fossa. American Journal of Ophthalmology 1997;123(3), 400-402.
3. Sridhar MS, Sharma S, Reddy MK, Mruthyunjaya P, Rao GN. Clinicomicrobiological Review of Nocardia Keratitis. Cornea 1998;17(1),17-22.
4. Mruthyunjaya P, Jumper JM, Patel D, McCallum R, Cox TA, Jaffe GJ. Diagnostic Yield of Vitrectomy in Eyes with Suspected Posterior Segment Malignancy or Infection. Ophthalmology. 2002;109(6):1123-9. 
5. Mruthyunjaya P, Stinnett S, Toth CA. Change in visual function following macular translocation with 360-degree retinectomy for neovascular age-related macular degeneration. Ophthalmology. 2004;111, 1715-1724.
6. Mruthyunjaya P, Stinnett S, Toth CA. Impact of fluorescein angiographic characteristics of macular lesions on outcomes after macular translocation 360 surgery in eyes with age-related macular degeneration. Retina. 2005; 25, 597-608.
7. Cahill M, Mruthyunjaya P, Bowes-Rickman C, Toth CA. Recurrence of retinal pigment epithelial changes after macular translocation with 360 degree peripheral retinectomy for geographic atrophy. Archives of Ophthalmology, 2005; 123, 935-8.
8. Mruthyunjaya P, Connor T, Wirostko WJ, Chandrashekhar R, Stinnett S, Lai JC, Deramo V, Tang J, Dev S, Postel EA, Fekrat S. Central retinal vein occlusion in patients on long-term Coumadin® anticoagulation (2005, in press Retina)